000			02356nam a22002897a 4500
003			OSt
005			20240305193746.0
008			221206b |||||||| |||| 00| 0 eng d
028			_b Phone: +255 28 298 3384
028			_b Fax: +255 28 298 3386
028			_b Email: vc@bugando.ac.tz
028			_b Website: www.bugando.ac.tz
040			_bEnglish _cDLC
041			_aEnglish
100			_aMajaliwa Mzombwe _946795
245			_aThe ethical imperative to treat NCDs during research in Africa
260			_aMwanza, Tanzania: _b Elsevier & _b Catholic University of Health and Allied Sciences [CUHAS – Bugando] _c2019/4/1
300			_aPages e406-e407
490			_vThe Lancet Global Health Volume 7 Issue 4
520			_aAs the rising prevalence and life-threatening consequences of non-communicable diseases (NCDs) in Africa have become more obvious,1 so too has the fact that many African health systems are ill-equipped to meet the health-care needs of local communities affected by NCDs.2 Meanwhile, the quantity of clinical research done in Africa continues to increase,3 and carries with it unique ethical questions, especially relating to the amount of NCD medical care that ought to be provided for participants involved in this research. Many African research participants, whether enrolled in studies that investigate NCDs or other diseases, will inevitably have NCDs, but have little to no access to NCD health care in their communities. NCDs present a unique challenge because, contrary to acute infectious processes, the treatment of NCDs is not usually urgent and a lack of care will not lead to immediate morbidity or mortality. As such, do researchers in Africa have a responsibility to provide ancillary NCD services to research participants? In light of the third UN High-Level Meeting on NCDs, our aim is to provoke a dialogue regarding ancillary NCD services in the context of research in Africa. We believe that this dialogue can be guided by several lessons learned during the HIV epidemic and by a moral responsibility to provide ancillary care as articulated by Richardson.4
700			_aBernard Desderius _921235
700			_a Saidi Kapiga _945137
700			_a Luke Smart _919617
700			_a Robert Peck _922817
856			_uhttps://doi.org/10.1016/S2214-109X(19)30066-X
942			_2ddc _cVM
999			_c19946 _d19946